From: Evaluation of potential association of metabolic syndrome in obese and non-obese PCOS women
Variable group | B | Wald | Significance | Exp B (95% CI) | |
---|---|---|---|---|---|
VAI | NO | 0.16 | 7.66 | 0.06 | 1.17 (1.04–1.32) |
O | 0.14 | 25.33 | 0.00 | 1.14**(1.08–1.21) | |
ASBI | NO | 0.30 | 0.00 | 0.99 | 1.35(0.00–8.63) |
O | − 9.85 | 0.15 | 0.69 | 0.00(0.00–9.26) | |
BAI | NO | 0.05 | 0.17 | 0.67 | 1.05(0.81–1.36) |
O | − 0.01 | 0.13 | 0.70 | 0.98(0.92–1.05) | |
FFMI | NO | − 0.22 | 0.37 | 0.54 | 0.80(0.39–1.63) |
O | 0.04 | 0.38 | 0.53 | 1.05(0.90–1.22) | |
FMI | NO | 0.55 | 3.38 | 0.06 | 1.73(0.96–3.13) |
O | 0.05 | 0.85 | 0.35 | 1.05(0.94–1.47) | |
WHt ratio | NO | 12.45 | 2.30 | 0.12 | 2.57(0.02–2.53) |
O | 2.62 | 1.20 | 0.27 | 13.79 (0.12–5.02) | |
W/H ratio | NO | 6.06 | 1.43 | 0.23 | 4.2(0.21–8.59) |
O | 6.51 | 5.00 | 0.02 | 6.7*(2.2–20.44) |